Vaxcyte, Inc. (FRA:5VA)
Germany · Delayed Price · Currency is EUR 37.00
-0.40 (-1.07%)
At close: Jan 9, 2026
Vaxcyte Market Cap
Vaxcyte has a market cap or net worth of €5.18 billion as of January 9, 2026. Its market cap has decreased by -50.35% in one year.
Market Cap
5.18B
Enterprise Value
3.78B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€37.00
Market Cap Chart
Since June 15, 2020, Vaxcyte's market cap has increased from 1.22B to 5.18B, an increase of 323.16%. That is a compound annual growth rate of 29.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 5.18B | 0.74% |
| Dec 31, 2025 | 5.14B | -47.80% |
| Dec 31, 2024 | 9.85B | 82.29% |
| Dec 29, 2023 | 5.41B | 52.56% |
| Dec 30, 2022 | 3.54B | 220.92% |
| Dec 31, 2021 | 1.10B | -0.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |